NCT00568750 2019-06-17Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal TumorsSwiss Cancer InstitutePhase 2 Completed47 enrolled
NCT00464620 2018-11-23Trial of Dasatinib in Advanced SarcomasSarcoma Alliance for Research through CollaborationPhase 2 Completed366 enrolled 16 charts